74
Participants
Start Date
March 1, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Tisseel®
"The investigational medical product (IMP) in this study is Tisseel®, which is a tissue sealer consisting of two components:~1. Sealer protein: Human fibrinogen as glue component and synthetic Aprotinin, which delays fibrinolysis.~2. Human thrombin: Thrombin is an unique molecule that functions both as a procoagulant and anticoagulant. It activates platelets through its receptor on the platelets and regulates its own. generation by activating coagulation factors V, VIII and even XI resulting in a burst of thrombin formation.~Its indications are a better hemostasis, enforcement of vessel/gastrointestinal sutures and tissue sutures (mesh grafts, flaps etc)."
Insel Gruppe AG, Bern
Baxter Healthcare Corporation
INDUSTRY
Insel Gruppe AG, University Hospital Bern
OTHER